Annals of Emergency Medicine
Volume 48, Issue 1 , Page 54.e1 , July 2006

Severe Sepsis and Septic Shock: Review of the Literature and Emergency Department Management Guidelines

  • H. Bryant Nguyen, MD, MS

      Affiliations

    • Loma Linda University, Loma Linda, CA
    • ,
  • Emanuel P. Rivers, MD, MPH

      Affiliations

    • Henry Ford Hospital, Detroit, MI
    • ,
  • Fredrick M. Abrahamian, DO

      Affiliations

    • Olive View–UCLA Medical Center, Sylmar, CA
    • ,
  • Gregory J. Moran, MD

      Affiliations

    • Olive View–UCLA Medical Center, Sylmar, CA
    • ,
  • Edward Abraham, MD

      Affiliations

    • University of Colorado, Denver, CO
    • ,
  • Stephen Trzeciak, MD

      Affiliations

    • Cooper University Hospital, Camden, NJ
    • ,
  • David T. Huang, MD, MPH

      Affiliations

    • University of Pittsburgh, Pittsburgh, PA
    • ,
  • Tiffany Osborn, MD

      Affiliations

    • University of Virginia, Charlottesville, VA
    • ,
  • Dennis Stevens, MD, PhD

      Affiliations

    • VA Medical Center, Boise, ID
    • ,
  • David A. Talan, MD

      Affiliations

    • Olive View–UCLA Medical Center, Sylmar, CA
    • Corresponding Author InformationAddress for reprints: David A. Talan, MD, Department of Emergency Medicine, Olive View-UCLA Medical Center, 14445 Olive View Drive, North Annex, Sylmar, CA 91342
    • ,
  • Emergency Department Sepsis Education Program and Strategies to Improve Survival (ED-SEPSIS) Working Group

Received 6 July 2005 ,Revised 20 January 2006 ,Accepted 14 February 2006.

References 

  1. Rangel-Frausto MS , Pittet D , Costigan M , et al.   The natural history of the systemic inflammatory response syndrome (SIRS) (a prospective study) . JAMA . 1995;273:117–123
  2. Angus DC , Wax RS . Epidemiology of sepsis (an update) . Crit Care Med . 2001;29:S109–S116
  3. Angus DC , Linde-Zwirble WT , Lidicker J , et al.   Epidemiology of severe sepsis in the United States (analysis of incidence, outcome, and associated costs of care) . Crit Care Med . 2001;29:1303–1310
  4. Houck PM , Bratzler DW , Nsa W , et al.   Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia . Arch Intern Med . 2004;164:637–644
  5. Rivers E , Nguyen B , Havstad S , et al.   Early goal-directed therapy in the treatment of severe sepsis and septic shock . N Engl J Med . 2001;345:1368–1377
  6. Bernard GR , Vincent JL , Laterre PF , et al.   Efficacy and safety of recombinant human activated protein C for severe sepsis . N Engl J Med. . 2001;344:699–709
  7. Annane D , Sebille V , Charpentier C , et al.   Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock . JAMA . 2002;288:862–871
  8. Whitney CG , Farley MM , Hadler J , et al.   Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States . N Engl J Med. . 2000;343:1917–1924
  9. Burke JP . Infection control (a problem for patient safety) . N Engl J Med. . 2003;348:651–656
  10. Weiss SJ , Derlet R , Arndahl J , et al.   Estimating the degree of emergency department overcrowding in academic medical centers (results of the National ED Overcrowding Study (NEDOCS)) . Acad Emerg Med . 2004;11:38–50
  11. Trzeciak S , Rivers EP . Emergency department overcrowding in the United States (an emerging threat to patient safety and public health) . Emerg Med J . 2003;20:402–405
  12. Blow O , Magliore L , Claridge JA , et al.   The golden hour and the silver day (detection and correction of occult hypoperfusion within 24 hours improves outcome from major trauma) . J Trauma . 1999;47:964–969
  13. Sackett DL . Rules of evidence and clinical recommendations on the use of antithrombotic agents . Chest . 1989;95:2S–4S
  14. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis . Crit Care Med. . 1992;20:864–874
  15. Vincent JL . Dear SIRS, I’m sorry to say that I don’t like you . Crit Care Med. . 1997;25:372–374
  16. Levy MM , Fink MP , Marshall JC , et al.   2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference . Intensive Care Med . 2003;29:530–538
  17. Marshall JC , Cook DJ , Christou NV , et al.   Multiple organ dysfunction score (a reliable descriptor of a complex clinical outcome) . Crit Care Med. . 1995;23:1638–1652
  18. Kochanek KD , Murphy SL , Anderson RN , et al.   Deaths (final data for 2002) . Natl Vital Stat Rep . 2004;53:1–115
  19. McCaig LF , Burt CW . National hospital ambulatory medical care survey (2003 emergency department survey) . Adv Data . 2005;1–38
  20. Sands KE , Bates DW , Lanken PN , et al.   Epidemiology of sepsis syndrome in 8 academic medical centers (Academic Medical Center Consortium Sepsis Project Working Group) . JAMA . 1997;278:234–240
  21. Beutler B . Inferences, questions and possibilities in toll-like receptor signalling . Nature . 2004;430:257–263
  22. Haeney MR . The role of the complement cascade in sepsis . J Antimicrob Chemother . 1998;41:41–46
  23. Aird WC . The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome . Blood . 2003;101:3765–3777
  24. Esmon CT . Protein C pathway in sepsis . Ann Med . 2002;34:598–605
  25. Karimova A , Pinsky DJ . The endothelial response to oxygen deprivation (biology and clinical implications) . Intensive Care Med . 2001;27:19–31
  26. Hotchkiss RS , Karl IE . The pathophysiology and treatment of sepsis . N Engl J Med. . 2003;348:138–150
  27. Bone RC . Sir Isaac Newton, sepsis, SIRS, and CARS . Crit Care Med. . 1996;24:1125–1128
  28. Brun-Buisson C , Doyon F , Carlet J , et al.   Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units: French ICU Group for Severe Sepsis . JAMA . 1995;274:968–974
  29. Estenssoro E , Gonzalez F , Laffaire E , et al.   Shock on admission day is the best predictor of prolonged mechanical ventilation in the ICU . Chest . 2005;127:598–603
  30. Rackow EC , Astiz ME . Pathophysiology and treatment of septic shock . JAMA . 1991;266:548–554
  31. Ogawa S , Koga S , Kuwabara K , et al.   Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels . Am J Physiol . 1992;262(3 pt 1):C546–C554
  32. Shreeniwas R , Koga S , Karakurum M , et al.   Hypoxia-mediated induction of endothelial cell interleukin-1 alpha (an autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface) . J Clin Invest . 1992;90:2333–2339
  33. Lawson CA , Yan SD , Yan SF , et al.   Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation . J Clin Invest. . 1997;99:1729–1738
  34. Erickson LA , Fici GJ , Lund JE , et al.   Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene . Nature . 1990;346:74–76
  35. Parrillo JE . Cardiovascular dysfunction in septic shock (new insights into a deadly disease) . Int J Cardiol . 1985;7:314–321
  36. Fink MP . Cytopathic hypoxia (mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis) . Crit Care Clin . 2001;17:219–237
  37. Jardin F , Fourme T , Page B , et al.   Persistent preload defect in severe sepsis despite fluid loading (a longitudinal echocardiographic study in patients with septic shock) . Chest . 1999;116:1354–1359
  38. Astiz ME , Rackow EC , Kaufman B , et al.   Relationship of oxygen delivery and mixed venous oxygenation to lactic acidosis in patients with sepsis and acute myocardial infarction . Crit Care Med. . 1988;16:655–658
  39. Parrillo JE , Burch C , Shelhamer JH , et al.   A circulating myocardial depressant substance in humans with septic shock (septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance) . J Clin Invest. . 1985;76:1539–1553
  40. Oudemans-van Straaten HM , Jansen PG , te Velthuis H , et al.   Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxemia . Intensive Care Med. . 1996;22:294–300
  41. Ruokonen E , Takala J , Kari A , et al.   Regional blood flow and oxygen transport in septic shock . Crit Care Med. . 1993;21:1296–1303
  42. Dahn MS , Lange P , Lobdell K , et al.   Splanchnic and total body oxygen consumption differences in septic and injured patients . Surgery . 1987;101:69–80
  43. Rivers EP , Ander DS , Powell D . Central venous oxygen saturation monitoring in the critically ill patient . Curr Opin Crit Care . 2001;7:204–211
  44. Scheinman MM , Brown MA , Rapaport E . Critical assessment of use of central venous oxygen saturation as a mirror of mixed venous oxygen in severely ill cardiac patients . Circulation . 1969;40:165–172
  45. Reinhart K , Kuhn HJ , Hartog C , et al.   Continuous central venous and pulmonary artery oxygen saturation monitoring in the critically ill . Intensive Care Med. . 2004;30:1572–1578
  46. Reinhart K , Rudolph T , Bredle DL , et al.   Comparison of central-venous to mixed-venous oxygen saturation during changes in oxygen supply/demand . Chest. . 1989;95:1216–1221
  47. Goldman RH , Klughaupt M , Metcalf T , et al.   Measurement of central venous oxygen saturation in patients with myocardial infarction . Circulation . 1968;38:941–946
  48. Berridge JC . Influence of cardiac output on the correlation between mixed venous and central venous oxygen saturation . Br J Anaesth . 1992;69:409–410
  49. Edwards JD , Mayall RM . Importance of the sampling site for measurement of mixed venous oxygen saturation in shock . Crit Care Med. . 1998;26:1356–1360
  50. Lee J , Wright F , Barber R , et al.   Central venous oxygen saturation in shock (a study in man) . Anesthesiology . 1972;36:472–478
  51. Scalea TM , Holman M , Fuortes M , et al.   Central venous blood oxygen saturation (an early, accurate measurement of volume during hemorrhage) . J Trauma . 1988;28:725–732
  52. Chawla LS , Zia H , Gutierrez G , et al.   Lack of equivalence between central and mixed venous oxygen saturation . Chest. . 2004;126:1891–1896
  53. Bernardin G , Pradier C , Tiger F , et al.   Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock . Intensive Care Med. . 1996;22:17–25
  54. Wo CC , Shoemaker WC , Appel PL , et al.   Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness . Crit Care Med. . 1993;21:218–223
  55. Rady M , Rivers EP , Nowak RM . Resuscitation of the critically ill in the ED (responses of blood pressure, heart rate, shock index, central venous saturation, and lactate) . Am J Emerg Med . 1996;2:218–225
  56. Fink MP . Cytopathic hypoxia (is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration?) . Crit Care Clin . 2002;18:165–175
  57. Norman DC , Yoshikawa TT . Fever in the elderly . Infect Dis Clin North Am . 1996;10:93–99
  58. Chassagne P , Perol MB , Doucet J , et al.   Is presentation of bacteremia in the elderly the same as in younger patients? . Am J Med. . 1996;100:65–70
  59. Morris DL , Chambers HF , Morris MG , et al.   Hemodynamic characteristics of patients with hypothermia due to occult infection and other causes . Ann Intern Med. . 1985;102:153–157
  60. Cornbleet PJ . Clinical utility of the band count . Clin Lab Med. . 2002;22:101–136
  61. Novak RW . The beleaguered band count . Clin Lab Med. . 1993;13:895–903
  62. Wenz B , Gennis P , Canova C , et al.   The clinical utility of the leukocyte differential in emergency medicine . Am J Clin Pathol. . 1986;86:298–303
  63. Ardron MJ , Westengard JC , Dutcher TF . Band neutrophil counts are unnecessary for the diagnosis of infection in patients with normal total leukocyte counts . Am J Clin Pathol. . 1994;102:646–649
  64. Callaham M . Inaccuracy and expense of the leukocyte count in making urgent clinical decisions . Ann Emerg Med. . 1986;15:774–781
  65. Kuppermann N , Walton EA . Immature neutrophils in the blood smears of young febrile children . Arch Pediatr Adolesc Med . 1999;153:261–266
  66. Vanderschueren S , De Weerdt A , Malbrain M , et al.   Thrombocytopenia and prognosis in intensive care . Crit Care Med. . 2000;28:1871–1876
  67. Powars D , Larsen R , Johnson J , et al.   Epidemic meningococcemia and purpura fulminans with induced protein C deficiency . Clin Infect Dis . 1993;17:254–261
  68. Fourrier F , Chopin C , Goudemand J , et al.   Septic shock, multiple organ failure, and disseminated intravascular coagulation (compared patterns of antithrombin III, protein C, and protein S deficiencies) . Chest. . 1992;101:816–823
  69. Kinasewitz GT , Yan SB , Basson B , et al.   Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism . Crit Care . 2004;8:R82–R90
  70. Shorr AF , Thomas SJ , Alkins SA , et al.   D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients . Chest. . 2002;121:1262–1268
  71. Kollef MH , Eisenberg PR , Shannon W . A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients . Crit Care Med. . 1998;26:1054–1060
  72. Levraut J , Bounatirou T , Ichai C , et al.   Reliability of anion gap as an indicator of blood lactate in critically ill patients . Intensive Care Med. . 1997;23:417–422
  73. Iberti TJ , Leibowitz AB , Papadakos PJ , et al.   Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients . Crit Care Med. . 1990;18:275–277
  74. Abramson D , Scalea TM , Hitchcock R , et al.   Lactate clearance and survival following injury . J Trauma. . 1993;35:584–588
  75. Bakker J , Gris P , Coffernils M , et al.   Serial blood lactate levels can predict the development of multiple organ failure following septic shock . Am J Surg. . 1996;171:221–226
  76. Shapiro NI , Howell MD , Talmor D , et al.   Serum lactate as a predictor of mortality in emergency department patients with infection . Ann Emerg Med. . 2005;45:524–528
  77. Nguyen HB , Rivers EP , Knoblich BP , et al.   Early lactate clearance is associated with improved outcome in severe sepsis and septic shock . Crit Care Med. . 2004;32:1637–1642
  78. Weil MH , Michaels S , Rackow EC . Comparison of blood lactate concentrations in central venous, pulmonary artery, and arterial blood . Crit Care Med. . 1987;15:489–490
  79. Murdoch IA , Turner C , Dalton RN . Arterial or mixed venous lactate measurement in critically ill children (is there a difference?) . Acta Paediatr . 1994;83:412–413
  80. Gallagher EJ , Rodriguez K , Touger M . Agreement between peripheral venous and arterial lactate levels . Ann Emerg Med. . 1997;29:479–483
  81. Marshall JC , Vincent JL , Fink MP , et al.   Measures, markers, and mediators: toward a staging system for clinical sepsis: a report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000 . Crit Care Med. . 2003;31:1560–1567
  82. Weinstein MP . Current blood culture methods and systems (clinical concepts, technology, and interpretation of results) . Clin Infect Dis. . 1996;23:40–46
  83. Cockerill FR , Wilson JW , Vetter EA , et al.   Optimal testing parameters for blood cultures . Clin Infect Dis. . 2004;38:1724–1730
  84. Mermel LA , Maki DG . Detection of bacteremia in adults (consequences of culturing an inadequate volume of blood) . Ann Intern Med. . 1993;119:270–272
  85. Lamy B , Roy P , Carret G , et al.   What is the relevance of obtaining multiple blood samples for culture? a comprehensive model to optimize the strategy for diagnosing bacteremia . Clin Infect Dis. . 2002;35:842–850
  86. Washington JA , Ilstrup DM . Blood cultures (issues and controversies) . Rev Infect Dis. . 1986;8:792–802
  87. Aronson MD , Bor DH . Blood cultures . Ann Intern Med. . 1987;106:246–253
  88. Mandell LA , Bartlett JG , Dowell SF , et al.   Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults . Clin Infect Dis. . 2003;37:1405–1433
  89. Boissinot M , Bergeron MG . Toward rapid real-time molecular diagnostic to guide smart use of antimicrobials . Curr Opin Microbiol. . 2002;5:478–482
  90. Hayes MA , Timmins AC , Yau EH , et al.   Elevation of systemic oxygen delivery in the treatment of critically ill patients . N Engl J Med. . 1994;330:1717–1722
  91. Gattinoni L , Brazzi L , Pelosi P , et al.   A trial of goal-oriented hemodynamic therapy in critically ill patients (SvO2 Collaborative Group) . N Engl J Med. . 1995;333:1025–1032
  92. Shoemaker WC , Appel PL , Kram HB , et al.   Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients . Chest. . 1988;94:1176–1186
  93. Marik PE , Varon J . Goal-directed therapy for severe sepsis . N Engl J Med. . 2002;346:1025–1026
  94. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine . Practice parameters for hemodynamic support of sepsis in adult patients in sepsis . Crit Care Med. . 1999;27:639–660
  95. Hollenberg SM , Ahrens TS , Annane D , et al.   Practice parameters for hemodynamic support of sepsis in adult patients (2004 update) . Crit Care Med. . 2004;32:1928–1948
  96. Shapiro NI , Howell M , Talmor D . A blueprint for a sepsis protocol . Acad Emerg Med. . 2005;12:352–359
  97. Dorman T , Breslow MJ , Lipsett PA , et al.   Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients . Crit Care Med. . 1998;26:1646–1649
  98. Schierhout G , Roberts I . Fluid resuscitation with colloid or crystalloid solutions in critically ill patients (a systematic review of randomised trials) . BMJ. . 1998;316:961–964
  99. Choi PT , Yip G , Quinonez LG , et al.   Crystalloids vs. colloids in fluid resuscitation (a systematic review) . Crit Care Med. . 1999;27:200–210
  100. Finfer S , Bellomo R , Boyce N , et al.   A comparison of albumin and saline for fluid resuscitation in the intensive care unit . N Engl J Med. . 2004;350:2247–2256
  101. Imm A , Carlson RW . Fluid resuscitation in circulatory shock . Crit Care Clin . 1993;9:313–333
  102. Groeneveld AB . Albumin and artificial colloids in fluid management (where does the clinical evidence of their utility stand?) . Crit Care . 2000;4:S16–S20
  103. Rudis MI , Basha MA , Zarowitz BJ . Is it time to reposition vasopressors and inotropes in sepsis? . Crit Care Med. . 1996;24:525–537
  104. Martin C , Papazian L , Perrin G , et al.   Norepinephrine or dopamine for the treatment of hyperdynamic septic shock? . Chest. . 1993;103:1826–1831
  105. Martin C , Viviand X , Leone M , et al.   Effect of norepinephrine on the outcome of septic shock . Crit Care Med. . 2000;28:2758–2765
  106. Bonfiglio MF , Dasta JF , Gregory JS , et al.   High-dose phenylephrine infusion in the hemodynamic support of septic shock . DICP. . 1990;24:936–939
  107. Gregory JS , Bonfiglio MF , Dasta JF , et al.   Experience with phenylephrine as a component of the pharmacologic support of septic shock . Crit Care Med. . 1991;19:1395–1400
  108. Gasic S , Eichler HG , Korn A . Effect of ketanserin on phenylephrine-dependent changes in splanchnic hemodynamics and systemic blood pressure in healthy subjects . J Cardiovasc Pharmacol. . 1985;7:219–223
  109. Holmes CL , Patel BM , Russell JA , et al.   Physiology of vasopressin relevant to management of septic shock . Chest. . 2001;120:989–1002
  110. Holmes CL , Walley KR , Chittock DR , et al.   The effects of vasopressin on hemodynamics and renal function in severe septic shock (a case series) . Intensive Care Med. . 2001;27:1416–1421
  111. Landry DW , Levin HR , Gallant EM , et al.   Vasopressin pressor hypersensitivity in vasodilatory septic shock . Crit Care Med. . 1997;25:1279–1282
  112. Malay MB , Ashton RC , Landry DW , et al.   Low-dose vasopressin in the treatment of vasodilatory septic shock . J Trauma. . 1999;47:699–703
  113. De Backer D , Creteur J , Silva E , et al.   Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock (which is best?) . Crit Care Med. . 2003;31:1659–1667
  114. Rady MY , Rivers EP , Nowak RM . Resuscitation of the critically ill in the ED (responses of blood pressure, heart rate, shock index, central venous oxygen saturation, and lactate) . Am J Emerg Med. . 1996;14:218–225
  115. Spronk PE , Ince C , Gardien MJ , et al.   Nitroglycerin in septic shock after intravascular volume resuscitation . Lancet . 2002;360:1395–1396
  116. Hebert PC , Wells G , Blajchman MA , et al.   A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care (Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group) . N Engl J Med. . 1999;340:409–417
  117. Vincent JL , Baron JF , Reinhart K , et al.   Anemia and blood transfusion in critically ill patients . JAMA. . 2002;288:1499–1507
  118. Qiu HB , Yang Y , Zhou SX , et al.   Prognostic value of dobutamine stress test in patients with septic shock . Acta Pharmacol Sin . 2001;22:71–75
  119. Rhodes A , Lamb FJ , Malagon I , et al.   A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock . Crit Care Med. . 1999;27:2361–2366
  120. Marik PE , Kaufman D . The effects of neuromuscular paralysis on systemic and splanchnic oxygen utilization in mechanically ventilated patients . Chest. . 1996;109:1038–1042
  121. Manthous CA , Hall JB , Kushner R , et al.   The effect of mechanical ventilation on oxygen consumption in critically ill patients . Am J Respir Crit Care Med. . 1995;151:210–214
  122. Donnino MW , Nguyen HB , Jacobsen G , et al.   Cryptic septic shock (a sub-analysis of early goal-directed therapy) . [abstract] Chest. . 2003;124:90S
  123. Bakker J , Schieveld SJ , Brinkert W . Serum lactate level as an indicator of tissue hypoxia in severely ill patients . Ned Tijdschr Geneeskd . 2000;144:737–741
  124. Vincent JL , Dufaye P , Berre J , et al.   Serial lactate determinations during circulatory shock . Crit Care Med. . 1983;11:449–451
  125. DuPont HL , Spink WW . Infections due to gram-negative organisms (an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center) . Medicine . 1969;48:307–332
  126. Freid MA , Vosti KL . The importance of underlying disease in patients with gram-negative bacteremia . Arch Intern Med. . 1968;121:418–423
  127. Bryant RE , Hood AF , Hood CE , et al.   Factors affecting mortality of gram-negative rod bacteremia . Arch Intern Med. . 1971;127:120–128
  128. Myerowitz RL , Medeiros AA , O’Brien TF . Recent experience with bacillemia due to gram-negative organisms . J Infect Dis . 1971;124:239–246
  129. Setia U , Gross PA . Bacteremia in a community hospital (spectrum and mortality) . Arch Intern Med. . 1977;137:1698–1701
  130. Weinstein MP , Reller LB , Murphy JR , et al.   The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults, I: laboratory and epidemiologic observations . Rev Infect Dis. . 1983;5:35–53
  131. Weinstein MP , Murphy JR , Reller LB , et al.   The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults, II: clinical observations, with special reference to factors influencing prognosis . Rev Infect Dis. . 1983;5:54–70
  132. McCue JD . Improved mortality in gram-negative bacillary bacteremia . Arch Intern Med. . 1985;145:1212–1216
  133. Ispahani P , Pearson NJ , Greenwood D . An analysis of community and hospital-acquired bacteraemia in a large teaching hospital in the United Kingdom . Q J Med . 1987;63:427–440
  134. Meyers BR , Sherman E , Mendelson MH , et al.   Bloodstream infections in the elderly . Am J Med. . 1989;86:379–384
  135. Leibovici L , Shraga I , Drucker M , et al.   The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection . J Intern Med . 1998;244:379–386
  136. Behrendt G , Schneider S , Brodt HR , et al.   Influence of antimicrobial treatment on mortality in septicemia . J Chemother . 1999;11:179–186
  137. Zaragoza R , Artero A , Camarena JJ , et al.   The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit . Clin Microbiol Infect . 2003;9:412–418
  138. Kollef MH , Sherman G , Ward S , et al.   Inadequate antimicrobial treatment of infections (a risk factor for hospital mortality among critically ill patients) . Chest. . 1999;115:462–474
  139. Kang CI , Kim SH , Kim HB , et al.   Pseudomonas aeruginosa bacteremia (risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome) . Clin Infect Dis. . 2003;37:745–751
  140. Ibrahim EH , Sherman G , Ward S , et al.   The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting . Chest. . 2000;118:146–155
  141. Yu VL , Chiou CC , Feldman C , et al.   An international prospective study of pneumococcal bacteremia (correlation with in vitro resistance, antibiotics administered, and clinical outcome) . Clin Infect Dis. . 2003;37:230–237
  142. Laterre PF , Garber G , Levy H , et al.   Severe community-acquired pneumonia as a cause of severe sepsis (data from the PROWESS study) . Crit Care Med. . 2005;33:952–961
  143. Cartwright K , Reilly S , White D , et al.   Early treatment with parenteral penicillin in meningococcal disease . BMJ. . 1992;305:143–147
  144. Meehan TP , Fine MJ , Krumholz HM , et al.   Quality of care, process, and outcomes in elderly patients with pneumonia . JAMA. . 1997;278:2080–2084
  145. Silber SH , Garrett C , Singh R , et al.   Early administration of antibiotics does not shorten time to clinical stability in patients with moderate-to-severe community-acquired pneumonia . Chest. . 2003;124:1798–1804
  146. The Medicare National Pneumonia Quality Improvement Project. Centers for Medicare Quality Improvement Community [Web site]. Available at: http://www.medqic.org. Accessed July 1, 2005.
  147. Siegman-Igra Y , Fourer B , Orni-Wasserlauf R , et al.   Reappraisal of community-acquired bacteremia (a proposal of a new classification for the spectrum of acquisition of bacteremia) . Clin Infect Dis. . 2002;34:1431–1439
  148. Friedman ND , Kaye KS , Stout JE , et al.   Health care-associated bloodstream infections in adults (a reason to change the accepted definition of community-acquired infections) . Ann Intern Med. . 2002;137:791–797
  149. Bochud PY , Glauser MP , Calandra T . Antibiotics in sepsis . Intensive Care Med. . 2001;27:S33–S48
  150. Abraham E , Wunderink R , Silverman H , et al.   Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial: TNF-alpha MAb Sepsis Study Group . JAMA. . 1995;273:934–941
  151. Brun-Buisson C , Doyon F , Carlet J . Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals: French Bacteremia-Sepsis Study Group . Am J Respir Crit Care Med. . 1996;154:617–624
  152. Cohen J , Carlet J . INTERSEPT: an international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis: International Sepsis Trial Study Group . Crit Care Med. . 1996;24:1431–1440
  153. McCabe WR , Jackson GG . Gram negative bacteremia . Arch Intern Med. . 1962;110:92–100
  154. Schumer W . Steroids in the treatment of clinical septic shock . Ann Surg . 1976;184:333–341
  155. Abraham E , Anzueto A , Gutierrez G , et al.   Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock (NORASEPT II Study Group) . Lancet . 1998;351:929–933
  156. Saravolatz LD , Wherry JC , Spooner C , et al.   Clinical safety, tolerability, and pharmacokinetics of murine monoclonal antibody to human tumor necrosis factor-alpha . J Infect Dis . 1994;169:214–217
  157. Kieft H , Hoepelman AI , Zhou W , et al.   The sepsis syndrome in a Dutch university hospital (clinical observations) . Arch Intern Med. . 1993;153:2241–2247
  158. Fisher CJ , Dhainaut JF , Opal SM , et al.   Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial: Phase III rhIL-1ra Sepsis Syndrome Study Group . JAMA. . 1994;271:1836–1843
  159. Fisher CJ , Slotman GJ , Opal SM , et al.   Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial: the IL-1RA Sepsis Syndrome Study Group . Crit Care Med. . 1994;22:12–21
  160. Reinhart K , Wiegand-Lohnert C , Grimminger F , et al.   Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock (a multicenter, randomized, placebo-controlled, dose-ranging study) . Crit Care Med. . 1996;24:733–742
  161. Dhainaut JF , Vincent JL , Richard C , et al.   CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock: CPD571 Sepsis Study Group . Crit Care Med. . 1995;23:1461–1469
  162. Opal SM , Fisher CJ , Dhainaut JF , et al.   Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial: the Interleukin-1 Receptor Antagonist Sepsis Investigator Group . Crit Care Med. . 1997;25:1115–1124
  163. Bernard GR , Wheeler AP , Russell JA , et al.   The effects of ibuprofen on the physiology and survival of patients with sepsis (the Ibuprofen in Sepsis Study Group) . N Engl J Med. . 1997;336:912–918
  164. Mylotte JM , Tayara A , Goodnough S . Epidemiology of bloodstream infection in nursing home residents (evaluation in a large cohort from multiple homes) . Clin Infect Dis. . 2002;35:1484–1490
  165. Martin GS , Mannino DM , Eaton S , et al.   The epidemiology of sepsis in the United States from 1979 through 2000 . N Engl J Med. . 2003;348:1546–1554
  166. Valles J , Rello J , Ochagavia A , et al.   Community-acquired bloodstream infection in critically ill adult patients (impact of shock and inappropriate antibiotic therapy on survival) . Chest. . 2003;123:1615–1624
  167. Karlowsky JA , Jones ME , Thornsberry C , et al.   Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999 . Int J Antimicrob Agents . 2001;18:121–127
  168. Karlowsky JA , Kelly LJ , Thornsberry C , et al.   Susceptibility to fluoroquinolones among commonly isolated gram-negative bacilli in 2000: TRUST and TSN data for the United States: Tracking Resistance in the United States Today: the Surveillance Network . Int J Antimicrob Agents . 2002;19:21–31
  169. Karlowsky JA , Kelly LJ , Thornsberry C , et al.   Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States . Antimicrob Agents Chemother . 2002;46:2540–2545
  170. Gupta K , Sahm DF , Mayfield D , et al.   Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women (a nationwide analysis) . Clin Infect Dis. . 2001;33:89–94
  171. Garau J , Xercavins M , Rodriguez-Carballeira M , et al.   Emergence and dissemination of quinolone-resistant Escherichia coli in the community . Antimicrob Agents Chemother . 1999;43:2736–2741
  172. Jones ME , Karlowsky JA , Blosser-Middleton R , et al.   Longitudinal assessment of antipneumococcal susceptibility in the United States . Antimicrob Agents Chemother. . 2002;46:2651–2655
  173. Pfaller MA , Ehrhardt AF , Jones RN . Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study (microbiology from the medical office practice environment) . Am J Med. . 2001;111:4S–12S
  174. Thornsberry C , Sahm DF , Kelly LJ , et al.   Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States (results from the TRUST Surveillance Program, 1999-2000) . Clin Infect Dis. . 2002;34:S4–S16
  175. Doern GV , Brown SD . Antimicrobial susceptibility among community-acquired respiratory tract pathogens in the USA (data from PROTEKT US 2000-01) . J Infect . 2004;48:56–65
  176. Karlowsky JA , Thornsberry C , Jones ME , et al.   Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States (results from the TRUST Surveillance Program (1998-2002)) . Clin Infect Dis. . 2003;36:963–970
  177. Chen DK , McGeer A , de Azavedo JC , et al.   Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada (Canadian Bacterial Surveillance Network) . N Engl J Med. . 1999;341:233–239
  178. Centers for Disease Control and Prevention . Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae (United States, 2003) . MMWR Morb Mortal Wkly Rep. . 2004;53:152–154
  179. Ho PL , Yung RW , Tsang DN , et al.   Increasing resistance of Streptococcus pneumoniae to fluoroquinolones (results of a Hong Kong multicentre study in 2000) . J Antimicrob Chemother . 2001;48:659–665
  180. Centers for Disease Control and Prevention . Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison (Mississippi, 2000) . MMWR Morb Mortal Wkly Rep. . 2001;50:919–922
  181. Centers for Disease Control and Prevention . Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus (Minnesota and North Dakota, 1997-1999) . JAMA. . 1999;282:1123–1125
  182. Salgado CD , Farr BM , Calfee DP . Community-acquired methicillin-resistant Staphylococcus aureus (a meta-analysis of prevalence and risk factors) . Clin Infect Dis. . 2003;36:131–139
  183. Centers for Disease Control and Prevention. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections-Los Angeles County, California, 2002-2003 . MMWR Morb Mortal Weekly Rep . 2002;52:88
  184. Fish DN , Piscitelli SC , Danziger LH . Development of resistance during antimicrobial therapy (a review of antibiotic classes and patient characteristics in 173 studies) . Pharmacotherapy . 1995;15:279–291
  185. Frazee BW , Lynn J , Charlebois ED , et al.   High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections . Ann Emerg Med. . 2005;45:311–320
  186. Moran GJ , Talan DA . Community-associated methicillin-resistant Staphylococcus aureus (is it in your community and should it change practice?) . Ann Emerg Med. . 2005;45:321–322
  187. Lewis JS , Jorgensen JH . Inducible clindamycin resistance in staphylococci (should clinicians and microbiologists be concerned?) . Clin Infect Dis. . 2005;40:280–285
  188. Acar JF . Antibiotic synergy and antagonism . Med Clin North Am . 2000;84:1391–1406
  189. Mylonakis E , Calderwood SB . Infective endocarditis in adults . N Engl J Med. . 2001;345:1318–1330
  190. Stevens DL . Streptococcal toxic-shock syndrome (spectrum of disease, pathogenesis, and new concepts in treatment) . Emerg Infect Dis . 1995;1:69–78
  191. Zimbelman J , Palmer A , Todd J . Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection . Pediatr Infect Dis J . 1999;18:1096–1100
  192. Bouza E , Munoz P . Monotherapy versus combination therapy for bacterial infections . Med Clin North Am . 2000;84:1357–1389
  193. Hilf M , Yu VL , Sharp J , et al.   Antibiotic therapy for Pseudomonas aeruginosa bacteremia (outcome correlations in a prospective study of 200 patients) . Am J Med. . 1989;87:540–546
  194. Chow JW , Yu VL . Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia (a commentary) . Int J Antimicrob Agents . 1999;11:7–12
  195. Mimoz O , Jacolot A , Padoin C , et al.   Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae . J Antimicrob Chemother . 1998;41:367–372
  196. Korvick JA , Bryan CS , Farber B , et al.   Prospective observational study of Klebsiella bacteremia in 230 patients (outcome for antibiotic combinations versus monotherapy) . Antimicrob Agents Chemother. . 1992;36:2639–2644
  197. Isaksson B , Hanberger H , Maller R , et al.   Synergic post-antibiotic effect of amikacin in combination with beta-lactam antibiotics on gram-negative bacteria . J Antimicrob Chemother . 1991;28:25–34
  198. Leibovici L , Paul M , Poznanski O , et al.   Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia (a prospective, observational study) . Antimicrob Agents Chemother. . 1997;41:1127–1133
  199. Hughes WT , Armstrong D , Bodey GP , et al.   2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer . Clin Infect Dis. . 2002;34:730–751
  200. Wunderink RG , Rello J , Cammarata SK , et al.   Linezolid vs vancomycin (analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia) . Chest. . 2003;124:1789–1797
  201. Kahn JB , Bahal N , Wiesinger BA , et al.   Cumulative clinical trial experience with levofloxacin for patients with community-acquired pneumonia-associated pneumococcal bacteremia . Clin Infect Dis. . 2004;38:S34–S42
  202. Quagliarello VJ , Scheld WM . Treatment of bacterial meningitis . N Engl J Med. . 1997;336:708–716
  203. Siberry GK , Tekle T , Carroll K , et al.   Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro . Clin Infect Dis. . 2003;37:1257–1260
  204. Jimenez MF , Marshall JC . International sepsis forum. Source control in the management of sepsis . Intensive Care Med . 2001;27:S49–S62
  205. Marshall JC , Maier RV , Jimenez M , et al.   Source control in the management of severe sepsis and septic shock (an evidence-based review) . Crit Care Med . 2004;32:S513–S526
  206. Ashbaugh DG . Empyema thoracis (factors influencing morbidity and mortality) . Chest. . 1991;99:1162–1165
  207. Light RW . A new classification of parapneumonic effusions and empyema . Chest. . 1995;108:299–301
  208. Colice GL , Curtis A , Deslauriers J , et al.   Medical and surgical treatment of parapneumonic effusions (an evidence-based guideline) . Chest. . 2000;118:1158–1171
  209. Light RW . Pleural diseases . Dis Mon . 1992;38:261–331
  210. Velmahos GC , Kamel E , Berne TV , et al.   Abdominal computed tomography for the diagnosis of intra-abdominal sepsis in critically injured patients (fishing in murky waters) . Arch Surg . 1999;134:831–836
  211. Barkhausen J , Stoblen F , Dominguez-Fernandez E , et al.   Impact of CT in patients with sepsis of unknown origin . Acta Radiol . 1999;40:552–555
  212. Taourel P , Baron MP , Pradel J , et al.   Acute abdomen of unknown origin (impact of CT on diagnosis and management) . Gastrointest Radiol . 1992;17:287–291
  213. Montgomery RS , Wilson SE . Intraabdominal abscesses (image-guided diagnosis and therapy) . Clin Infect Dis. . 1996;23:28–36
  214. Knochel JQ , Koehler PR , Lee TG , et al.   Diagnosis of abdominal abscesses with computed tomography, ultrasound, and 111In leukocyte scans . Radiology . 1980;137:425–432
  215. Paulson EK , Kalady MF , Pappas TN . Clinical practice (suspected appendicitis) . N Engl J Med. . 2003;348:236–242
  216. Goletti O , Lippolis PV , Chiarugi M , et al.   Percutaneous ultrasound-guided drainage of intra-abdominal abscesses . Br J Surg . 1993;80:336–339
  217. Gazelle GS , Mueller PR . Abdominal abscess (imaging and intervention) . Radiol Clin North Am . 1994;32:913–932
  218. Wyatt SH , Urban BA , Fishman EK . Spiral CT of the kidneys: role in characterization of renal disease, part I: nonneoplastic disease . Crit Rev Diagn Imaging . 1995;36:1–37
  219. Henderson SO , Hoffner RJ , Aragona JL , et al.   Bedside emergency department ultrasonography plus radiography of the kidneys, ureters, and bladder vs intravenous pyelography in the evaluation of suspected ureteral colic . Acad Emerg Med. . 1998;5:666–671
  220. St Lezin M , Hofmann R , Stoller ML . Pyonephrosis (diagnosis and treatment) . Br J Urol . 1992;70:360–363
  221. Pearle MS , Pierce HL , Miller GL , et al.   Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi . J Urol . 1998;160:1260–1264
  222. Barbaric ZL . Percutaneous nephrostomy for urinary tract obstruction . AJR Am J Roentgenol . 1984;143:803–809
  223. Deyoe LA , Cronan JJ , Lambiase RE , et al.   Percutaneous drainage of renal and perirenal abscesses (results in 30 patients) . AJR Am J Roentgenol . 1990;155:81–83
  224. Lang EK . Renal, perirenal, and pararenal abscesses (percutaneous drainage) . Radiology . 1990;174:109–113
  225. Gerzof SG . Percutaneous drainage of renal and perinephric abscess . Urol Radiol . 1981;2:171–179
  226. Tang HJ , Li CM , Yen MY , et al.   Clinical characteristics of emphysematous pyelonephritis . J Microbiol Immunol Infect . 2001;34:125–130
  227. Huang JJ , Tseng CC . Emphysematous pyelonephritis (clinicoradiological classification, management, prognosis, and pathogenesis) . Arch Intern Med. . 2000;160:797–805
  228. Riedl CR , Plas E , Hubner WA , et al.   Bacterial colonization of ureteral stents . Eur Urol . 1999;36:53–59
  229. Warren JW . Catheter-associated urinary tract infections . Infect Dis Clin North Am . 1997;11:609–622
  230. Elliott DC , Kufera JA , Myers RA . Necrotizing soft tissue infections (risk factors for mortality and strategies for management) . Ann Surg . 1996;224:672–683
  231. McHenry CR , Piotrowski JJ , Petrinic D , et al.   Determinants of mortality for necrotizing soft-tissue infections . Ann Surg . 1995;221:558–563
  232. Green RJ , Dafoe DC , Raffin TA . Necrotizing fasciitis . Chest. . 1996;110:219–229
  233. Fisher JR , Conway MJ , Takeshita RT , et al.   Necrotizing fasciitis (importance of roentgenographic studies for soft-tissue gas) . JAMA. . 1979;241:803–806
  234. Wysoki MG , Santora TA , Shah RM , et al.   Necrotizing fasciitis (CT characteristics) . Radiology . 1997;203:859–863
  235. Schmid MR , Kossmann T , Duewell S . Differentiation of necrotizing fasciitis and cellulitis using MR imaging . AJR Am J Roentgenol . 1998;170:615–620
  236. Chow AW , Galpin JE , Guze LB . Clindamycin for treatment of sepsis caused by decubitus ulcers . J Infect Dis . 1977;135:S65–S68
  237. Galpin JE , Chow AW , Bayer AS , et al.   Sepsis associated with decubitus ulcers . Am J Med. . 1976;61:346–350
  238. McGee DC , Gould MK . Preventing complications of central venous catheterization . N Engl J Med. . 2003;348:1123–1133
  239. Mermel LA , Farr BM , Sherertz RJ , et al.   Guidelines for the management of intravascular catheter-related infections . Clin Infect Dis. . 2001;32:1249–1272
  240. Siegel JP . Assessing the use of activated protein C in the treatment of severe sepsis . N Engl J Med. . 2002;347:1030–1034
  241. Taylor FB , Chang A , Esmon CT , et al.   Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon . J Clin Invest. . 1987;79:918–925
  242. Hirose K , Okajima K , Taoka Y , et al.   Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation . Ann Surg . 2000;232:272–280
  243. Bernard GR , Ely EW , Wright TJ , et al.   Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis . Crit Care Med. . 2001;29:2051–2059
  244. Knaus WA , Draper EA , Wagner DP , et al.   APACHE II (a severity of disease classification system) . Crit Care Med. . 1985;13:818–829
  245. FDA briefing document: Drotrecogin alfa (activated) [recombinant human activated protein C (rhAPC)] Xigris, BLA#125029/0 [US Food and Drug Administration Web site]. Available at: http://www.fda.gov/ohrms/dockets/ac/01/briefing/3797b1.htm. Accessed October 2005.
  246. Abraham E , Laterre PF , Garg R , et al.   Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death . N Engl J Med. . 2005;353:1332–1341
  247. Discontinuation of Study F1K-MC-EVBP, Investigation of the Efficacy and Safety of Droctrecognin Alfa (activated) in Pediatric Severe Sepsis, Eli Lilly, April 21, 2005. Available at: http://www.fda.gov/medwatch/safety/2005/xigris_dearhcp_4-21-05.pdf. Accessed January 6, 2005.
  248. Warren HS , Suffredini AF , Eichacker PQ , et al.   Risks and benefits of activated protein C treatment for severe sepsis . N Engl J Med. . 2002;347:1027–1030
  249. Ely EW , Bernard GR , Vincent JL . Activated protein C for severe sepsis . N Engl J Med. . 2002;347:1035–1036
  250. Opal SM , Cross AS . Clinical trials for severe sepsis (past failures, and future hopes) . Infect Dis Clin North Am . 1999;13:285–297
  251. Angus DC , Linde-Zwirble WT , Clermont G , et al.   Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis . Crit Care Med. . 2003;31:1–11
  252. Manns BJ , Lee H , Doig CJ , et al.   An economic evaluation of activated protein C treatment for severe sepsis . N Engl J Med. . 2002;347:993–1000
  253. Polderman KH , Jorna EM , Girbes AR . Inter-observer variability in APACHE II scoring (effect of strict guidelines and training) . Intensive Care Med . 2001;27:1365–1369
  254. Ely EW , Laterre PF , Angus DC , et al.   Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis . Crit Care Med. . 2003;31:12–19
  255. Angus DC , Laterre PF , Helterbrand J , et al.   The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis . Crit Care Med. . 2004;32:2199–2206
  256. Haley M , Cui X , Minneci PC , et al.   Recombinant human activated protein C in sepsis (previous concerns and current usage) . Therapy . 2004;2004:123–129
  257. Vincent JL , Bernard GR , Beale R , et al.   Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE (further evidence for survival and safety and implications for early treatment) . Crit Care Med. . 2005;33:2266–2277
  258. Vincent JL , Levy MM , Macias WL , et al.   Early intervention with drotrecogin alfa (activated) improves survival benefit . Crit Care Med. . 2003;31:A123
  259. Johnston JA , Pulgar S , Ball DE , et al.   The impact of timely drotrecogin alfa (activated) administration on hospital mortality and resource use . Crit Care Med. . 2003;31:A73
  260. Wheeler A , Steingrub J , Linde-Zwirble W , et al.   Prompt administration of drotrecogin alfa (activated) is associated with improved survival . Crit Care Med. . 2003;31:A120
  261. Verceles A , Schwarcz R , Birnbaum P , et al.   Factors influencing survival in patients receiving activated protein C . Crit Care Med. . 2003;31:A126
  262. Nguyen HB , Corbett SW , Menes K , et al.   Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department . Acad Emerg Med. . 2006;13:109–113
  263. Rothwell PM , Udwadia ZF , Lawler PG . Cortisol response to corticotropin and survival in septic shock . Lancet . 1991;337:582–583
  264. Soni A , Pepper GM , Wyrwinski PM , et al.   Adrenal insufficiency occurring during septic shock (incidence, outcome, and relationship to peripheral cytokine levels) . Am J Med. . 1995;98:266–271
  265. Lamberts SW , Bruining HA , de Jong FH . Corticosteroid therapy in severe illness . N Engl J Med. . 1997;337:1285–1292
  266. Annane D , Sebille V , Troche G , et al.   A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin . JAMA. . 2000;283:1038–1045
  267. Cooper MS , Stewart PM . Corticosteroid insufficiency in acutely ill patients . N Engl J Med. . 2003;348:727–734
  268. Rivers EP , Blake HC , Dereczyk B , et al.   Adrenal dysfunction in hemodynamically unstable patients in the emergency department . Acad Emerg Med. . 1999;6:626–630
  269. Briegel J , Forst H , Haller M , et al.   Stress doses of hydrocortisone reverse hyperdynamic septic shock (a prospective, randomized, double-blind, single-center study) . Crit Care Med. . 1999;27:723–732
  270. Bollaert PE , Charpentier C , Levy B , et al.   Reversal of late septic shock with supraphysiologic doses of hydrocortisone . Crit Care Med. . 1998;26:645–650
  271. Annane D , Briegel J , Keh D , et al.   Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone . Crit Care Med. . 2003;31:2250–2251
  272. Yamashita S , Drynan J , Guest C , et al.   Comparison of low-dose (1 mcg) with conventional dose cosyntropin (250 mcg) for adrenal insufficiency testing in critical illness . Crit Care Med. . 2001;29:A164
  273. Marik PE , Zaloga GP . Adrenal insufficiency during septic shock . Crit Care Med. . 2003;31:141–145
  274. Hamrahian AH , Oseni TS , Arafah BM . Measurements of serum free cortisol in critically ill patients . N Engl J Med. . 2004;350:1629–1638
  275. Opal SM . Corticosteroids for patients with septic shock . JAMA. . 2003;289:41–42
  276. Millo J . Corticosteroids for patients with septic shock . JAMA. . 2003;289:41
  277. Annane D , Bellissant E , Bollaert PE , et al.   Corticosteroids for severe sepsis and septic shock (a systematic review and meta-analysis) . BMJ. . 2004;329:480
  278. The Acute Respiratory Distress Syndrome Network . Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome . N Engl J Med. . 2000;342:1301–1308
  279. Aduen J , Bernstein WK , Khastgir T , et al.   The use and clinical importance of a substrate-specific electrode for rapid determination of blood lactate concentrations . JAMA. . 1994;272:1678–1685
  280. Grzybowski M . Systemic inflammatory response syndrome criteria and lactic acidosis in the detection of critical illness among patients presenting to the emergency department . Chest. . 1996;110:145S
  281. Frank ED . A shock team in a general hospital . Anesth Analg . 1967;46:740–745
  282. Buist MD , Moore GE , Bernard SA , et al.   Effects of a medical emergency team on reduction of incidence of and mortality from unexpected cardiac arrests in hospital (preliminary study) . BMJ. . 2002;324:387–390
  283. Sebat F , Johnson D , Musthafa AA , et al.   A multidisciplinary community hospital program for early and rapid resuscitation of shock in nontrauma patients . Chest. . 2005;127:1729–1743
  284. Dellinger RP , Carlet JM , Masur H , et al.   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock . Crit Care Med. . 2004;32:858–872
  285. Osborn TM , Nguyen HB , Rivers EP . Emergency medicine and the surviving sepsis campaign (an international approach to managing severe sepsis and septic shock) . Ann Emerg Med. . 2005;46:228–231
  286. Sepsis bundle. Available at: http://www.ihi.org/IHI/Topics/CriticalCare/Sepsis. Accessed October 2005.
  287. Dellinger RP , Carlet JM , Masur H , et al.   Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock . Intensive Care Med. . 2004;30:536–555

 Supervising editors: Kathy J. Rinnert, MD, MPH; Michael L. Callaham, MDFunding and support: The meeting of the ED-SEPSIS Executive Committee held in March 2004 was supported by grants from Physician’s Weekly, Eli Lilly, and Ortho McNeill.

PII: S0196-0644(06)00248-4

doi: 10.1016/j.annemergmed.2006.02.015

Annals of Emergency Medicine
Volume 48, Issue 1 , Page 54.e1 , July 2006

Article Tools

* Image Usage & Resolution